Respiratory drugs, antihistamines and anaphylaxis
Beta-2 agonists, antimuscarinics, corticosteroids, magnesium, methylxanthines and leukotriene antagonists in airway disease; H1 and H2 antihistamines; and the pharmacology of anaphylaxis, with adrenaline at its centre.
By the end of this page you should be able to
- Describe the mechanisms by which airway smooth muscle contracts and relaxes, and where each class of respiratory drug acts.
- Describe the pharmacology and adverse effects of salbutamol, including hypokalaemia and lactic acidosis.
- Compare short and long-acting bronchodilators and explain the role of inhaled and systemic corticosteroids.
- Compare first and second-generation H1 antihistamines.
- Explain the actions of adrenaline in anaphylaxis and why other drugs are second line.
How airway smooth muscle is controlled
Airway smooth muscle contracts when intracellular calcium rises: M3 receptors (vagal acetylcholine), H1 receptors and cysteinyl leukotriene (CysLT1) receptors couple to Gq, which forms IP3 and releases calcium; calcium-calmodulin activates myosin light chain kinase. It relaxes when cAMP rises: beta-2 receptors couple to Gs, adenylyl cyclase makes cAMP, and protein kinase A lowers calcium, inhibits myosin light chain kinase and opens potassium channels. So bronchodilators either raise cAMP (beta-2 agonists, and phosphodiesterase inhibitors that slow its breakdown) or block contraction (antimuscarinics, leukotriene antagonists). Corticosteroids treat the inflammation underneath.
Beta-2 agonists
- Salbutamol: short-acting, relatively selective beta-2 agonist. Inhaled onset within minutes, lasting about 4 to 6 hours. Also stabilises mast cells and improves mucociliary clearance.
- Adverse effects follow from beta receptors elsewhere: tremor (skeletal muscle beta-2), tachycardia and palpitations (cardiac beta-2 and some beta-1, plus reflex from vasodilation), hypokalaemia (beta-2 stimulation of Na/K ATPase shifts potassium into cells; the same reason salbutamol is used in hyperkalaemia), hyperglycaemia and lactic acidosis (glycogenolysis and glycolysis make more pyruvate than can be oxidised). A falling pH with a rising lactate on salbutamol, in an improving patient, is often the drug rather than worsening asthma.
- Salbutamol can briefly lower PaO2 in acute asthma: it dilates pulmonary vessels and reverses hypoxic pulmonary vasoconstriction in poorly ventilated areas, worsening V/Q mismatch. Give it with oxygen as needed.
- Long-acting beta-2 agonists (LABA): salmeterol (slow onset, highly lipophilic, held in the membrane near the receptor) and formoterol (fast onset, used for both reliever and maintenance with budesonide). In asthma a LABA is always given with an inhaled corticosteroid; LABA alone increases the risk of severe attacks.
Other bronchodilators and controllers
- Ipratropium: quaternary muscarinic antagonist, inhaled; little systemic absorption and no CNS effects. Added to salbutamol in severe acute asthma and in COPD. Tiotropium is the long-acting version. Can precipitate angle-closure glaucoma if the mist reaches the eye.
- Inhaled corticosteroids (budesonide, fluticasone, beclometasone): bind the cytoplasmic glucocorticoid receptor, which moves to the nucleus to switch off inflammatory genes (cytokines, adhesion molecules) and switch on anti-inflammatory ones. They also upregulate beta-2 receptors. Local adverse effects: oral thrush and hoarseness. Systemic steroids in acute asthma take hours to act, so they are given early.
- Magnesium sulfate IV: used in severe acute asthma. It blocks calcium entry into smooth muscle and reduces acetylcholine release. Adverse effects: flushing, hypotension, and at high levels loss of reflexes and respiratory depression.
- Theophylline and aminophylline: non-selective phosphodiesterase inhibitors and adenosine receptor antagonists. Narrow therapeutic index; cleared by CYP1A2, so smoking lowers levels while ciprofloxacin and erythromycin raise them. Toxicity: vomiting, tachyarrhythmias, hypokalaemia, hyperglycaemia and seizures. Little used now.
- Montelukast: CysLT1 receptor antagonist, oral, for prevention (including exercise and aspirin-exacerbated asthma). Carries a warning for neuropsychiatric effects such as sleep disturbance, agitation and suicidal thinking.
Antihistamines
H1 antihistamines are inverse agonists: they stabilise the inactive form of the receptor. First-generation drugs (promethazine, dexchlorpheniramine, diphenhydramine, doxylamine) are lipophilic, cross the blood-brain barrier and are sedating; they also block muscarinic, alpha-1 and (in overdose) cardiac sodium and potassium channels, so overdose causes an anticholinergic toxidrome, seizures and QT or QRS prolongation. IV promethazine is an irritant: extravasation or intra-arterial injection can cause severe tissue injury and gangrene. Second-generation drugs (loratadine, cetirizine, fexofenadine) are less lipophilic and are pumped out of the brain by P-glycoprotein, so they sedate little. H2 antagonists (famotidine) reduce gastric acid.
Anaphylaxis
Allergen cross-links IgE on mast cells and basophils, which release preformed histamine and tryptase and then make leukotrienes, prostaglandins and platelet activating factor. The result is vasodilation and capillary leak (distributive shock with hypovolaemia), bronchospasm, mucosal oedema and, at times, myocardial depression.
Adrenaline is the only first-line drug because it acts on every part of the problem: alpha-1 vasoconstriction restores tone and reduces mucosal oedema; beta-1 raises contractility and rate; beta-2 relaxes airway smooth muscle and, by raising cAMP in mast cells, reduces further mediator release. It is given intramuscularly into the anterolateral thigh (weight-based, repeated if needed; see ASCIA guidance and the Australian Medicines Handbook for doses) because absorption from muscle is faster and more reliable than from subcutaneous tissue, where adrenaline constricts its own vessels. Refractory cases need an IV adrenaline infusion and fluids.
Antihistamines treat itch and urticaria only; they do not treat airway obstruction or shock, and sedating ones can mask deterioration. Corticosteroids are slow and have no proven role in preventing biphasic reactions. Patients on beta blockers may resist adrenaline; glucagon raises cAMP through its own receptor and can help. ACE inhibitor angioedema is driven by bradykinin, not mast cells, so it often does not respond to these drugs at all.
Making the answer flow
- Start with the second messenger: Gq and calcium contract, Gs and cAMP relax. Every drug then slots into place.
- For salbutamol, organise adverse effects by receptor and by metabolic effect, and explain each one.
- For adrenaline in anaphylaxis, give a receptor, an effect and the problem it fixes, then the route and why.
Where marks are lost
- Calling antihistamines or corticosteroids first-line treatment for anaphylaxis.
- Attributing a rising lactate on nebulised salbutamol to tiring muscles without considering the drug.
- Saying LABAs can be used alone in asthma.
- Calling H1 antihistamines competitive antagonists without knowing they are inverse agonists.
- Forgetting CYP1A2 interactions with theophylline.
Where this meets anaesthesia
- Neuromuscular blockers and antibiotics are the commonest causes of perioperative anaphylaxis; take serum tryptase samples at the right times and refer for testing.
- Volatile agents are bronchodilators, but airway instrumentation in an asthmatic at a light plane can trigger severe bronchospasm.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Describe the pharmacology of salbutamol.
Show answer
- Short-acting, relatively selective beta-2 agonist; Gs, adenylyl cyclase, cAMP, protein kinase A; smooth muscle relaxation.
- Inhaled (MDI with spacer or nebulised), IV in severe cases; rapid onset, duration about 4 to 6 hours; hepatic sulfation, renal excretion.
- Uses: asthma, COPD, hyperkalaemia.
- Adverse: tremor, tachycardia, hypokalaemia, hyperglycaemia, lactic acidosis, transient fall in PaO2.
- 2.
Why does salbutamol cause lactic acidosis?
Show answer
- Beta-2 stimulation increases glycogenolysis and glycolysis, raising pyruvate production.
- Pyruvate exceeds what pyruvate dehydrogenase and the mitochondria can oxidise, so it is reduced to lactate (type B lactic acidosis, not tissue hypoxia).
- Can drive tachypnoea and be mistaken for worsening asthma; often settles when the dose is reduced.
- 3.
How does adrenaline work in anaphylaxis, and why is it given intramuscularly?
Show answer
- Alpha-1: vasoconstriction, reverses vasodilation and reduces mucosal oedema.
- Beta-1: inotropy and chronotropy; beta-2: bronchodilation and reduced mast cell mediator release.
- IM into the anterolateral thigh: faster and higher peak concentrations than subcutaneous (where local vasoconstriction slows absorption); safer than IV bolus in untrained hands.
- Repeated if the response is inadequate; refractory cases need an IV infusion with monitoring.
- 4.
A patient on metoprolol has anaphylaxis that does not respond to adrenaline. What is happening and what can you do?
Show answer
- Beta blockade blunts the beta-1 and beta-2 effects of adrenaline; unopposed alpha effects may also cause reflex bradycardia.
- Glucagon acts through its own Gs-coupled receptor to raise cAMP in the heart, bypassing the beta receptor.
- Continue adrenaline infusion, fluids, and consider other vasopressors.
- 5.
Compare promethazine and loratadine.
Show answer
- Both H1 inverse agonists.
- Promethazine: first generation phenothiazine; crosses blood-brain barrier; sedation, anticholinergic and alpha-blocking effects; used as antiemetic and sedative; IV tissue injury.
- Loratadine: second generation; poor CNS penetration (P-glycoprotein); minimal sedation; once daily; for allergic rhinitis and urticaria.
- Neither treats the airway or circulation in anaphylaxis.
- 6.
How do corticosteroids help in asthma?
Show answer
- Lipophilic; bind cytoplasmic glucocorticoid receptor; complex moves to the nucleus.
- Transrepression: switch off genes for cytokines, chemokines and adhesion molecules (in part by recruiting histone deacetylase); transactivation: anti-inflammatory proteins.
- Reduce eosinophils and mast cells in the airway, reduce oedema and hyperresponsiveness; upregulate beta-2 receptors.
- Onset takes hours, so give early in acute asthma.
- 7.
What is the role of magnesium in acute severe asthma?
Show answer
- IV magnesium sulfate as an add-on in severe or life-threatening asthma not responding to initial bronchodilators.
- Physiological calcium antagonist in smooth muscle; reduces acetylcholine release; may stabilise mast cells.
- Adverse effects: flushing, hypotension; high levels cause hyporeflexia, weakness and respiratory depression; caution in renal impairment.
- 8.
Describe theophylline toxicity and why the drug has fallen out of use.
Show answer
- Non-selective PDE inhibition and adenosine antagonism; narrow therapeutic index.
- Toxicity: vomiting, tachyarrhythmias, hypokalaemia, hyperglycaemia, seizures (adenosine antagonism lowers the seizure threshold).
- Saturable, CYP1A2-dependent clearance with many interactions; better, safer alternatives exist.
- Severe toxicity can be removed by haemodialysis.
- 9.
Why do ACE inhibitor angioedema and anaphylaxis respond differently to treatment?
Show answer
- Anaphylaxis: IgE-mediated mast cell degranulation; responds to adrenaline.
- ACE inhibitor angioedema: ACE normally degrades bradykinin; accumulated bradykinin acts on B2 receptors causing vascular leak.
- No urticaria or itch; adrenaline, antihistamines and steroids often fail; airway management is the priority; bradykinin pathway treatments have been tried with mixed results.
Practise this week
- Ventilator Waveform Reader
- Primary MCQs: pharmacology
- Primary SAQs, marked part by part
- Primary vivas
- Viva Examiner: practise answering aloud
Week 6 in the other subjects
- Physiology: Diffusion and oxygen transport
- Measurement and equipment: Breathing systems, carbon dioxide absorption and scavenging
- Procedural anatomy: Thoracic wall, pleura and lungs
Not affiliated with the Australian and New Zealand College of Anaesthetists (ANZCA). Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.